Expanding the prion disease repertoire

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 38, 2015, Pages 11748-11749

  Supattapone, Surachai ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PRION;

HUMAN; NONHUMAN; NOTE; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SHY DRAGER SYNDROME; ANIMAL; FEMALE; MALE; METABOLISM; PARKINSONISM;

ALPHA-SYNUCLEIN; ANIMALS; FEMALE; HUMANS; MALE; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; PRIONS;

EID: 84942903266     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1515143112     Document Type: Note

References (13)

1. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216(4542):136-144.
2. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95(23):13363-13383.
3. Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 104(23):9741-9746.
4. Prusiner SB, et al. (2015) Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA 112:E5308-E5317.
5. Walker LC, Jucker M (2015) Neurodegenerative diseases: Expanding the prion concept. Annu Rev Neurosci 38:87-103.
6. Meyer-Luehmann M, et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313(5794):1781-1784.
7. Clavaguera F, et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11(7):909-913.
8. Luk KC, et al. (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338(6109):949-953.
9. Deleault NR, et al. (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci USA 109(28):E1938-E1946.
10. Martí MJ, Tolosa E, Campdelacreu J (2003) Clinical overview of the synucleinopathies. Mov Disord 18(Suppl 6):S21-27.
11. Watts JC, et al. (2013) Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci USA 110(48):19555-19560.
12. Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA (2001) Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 49(3):313-319.
13. Noble GP, Walsh DJ, Miller MB, Jackson WS, Supattapone S (2015) Requirements for mutant and wild-type prion protein misfolding in vitro. Biochemistry 54(5):1180-1187.